antitrust

News

Sanofi faces EU investigation over flu shot marketing

The European Commission is investigating a marketing campaign run by Sanofi for a flu vaccine, to see if it disparaged its only rival in the market.

News

Jury finds Takeda liable for $885m in pay-for-delay lawsuit

Takeda is on the hook for $885m damages – which could rise to $2.5bn – in a suit claiming it paid a rival to delay the launch of a generic competitor.

News

Sanofi faces EU antitrust probe into vaccine business

Sanofi has confirmed it is being investigated by the European Commission for potentially anticompetitive activity in its vaccines business.

News

Novo’s $16.5bn Catalent deal cleared by EU Commission

EU says Novo Holdings’ $16.5 billion takeover of US contract development and manufacturing organisation Catalent does not pose antitrust issues.

News

Teva fined €462.6m for antitrust delay to MS drug rivals

The European Commission has delivered a hefty fine to Teva for abusing a dominant position in multiple sclerosis by artificially extending the patent protection for former blockbuster Copax

News

Lawmaker asks FTC to probe Novo/Catalent deal

US Senator Elizabeth Warren has asked the Federal Trade Commission (FTC) to look into a $16.5 billion deal that would give Novo Nordisk control of manufacturing facilities currently operate

Sanofi faces EU investigation over flu shot marketing

Jury finds Takeda liable for $885m in pay-for-delay lawsuit

Sanofi faces EU antitrust probe into vaccine business

Novo’s $16.5bn Catalent deal cleared by EU Commission

Teva fined €462.6m for antitrust delay to MS drug rivals

Lawmaker asks FTC to probe Novo/Catalent deal

FDA clears Viridian's Tepezza rival for thyroid eye disease

Discover a new era of healthcare panel engagement: Grounded ...

antitrust

Editor's Picks